Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peptide Vaccination With PD-L1 and PD-L2 Peptides in Untreated Chronic Lymphatic Leukemia.

NCT03939234 is registered in ClinicalTrials.gov with Lars Møller Pedersen as lead sponsor.

NCT NCT03939234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03939234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peptide Vaccination With PD-L1 and PD-L2 Peptides in Untreated Chronic Lymphatic Leukemia.
Lead sponsor
Lars Møller Pedersen
Phase
Phase 2
Overall status
Completed
Start date
April 26, 2019
Completion date
March 15, 2021
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia